Today: 19 May 2026
AMD stock price jumps in premarket as OpenAI eyes Nvidia alternatives ahead of earnings
3 February 2026
1 min read

AMD stock price jumps in premarket as OpenAI eyes Nvidia alternatives ahead of earnings

New York, February 3, 2026, 05:00 EST — Premarket

Advanced Micro Devices shares climbed roughly 4% in early trading Tuesday, reaching $246.27. The stock had ended the prior session at $236.82.

After the close, the chipmaker will release its earnings, with investors betting on another solid quarter from its data-center segment. Wall Street forecasts adjusted EPS of $1.32 on revenue near $9.7 billion for the December quarter, including about $5 billion from data centers, based on consensus estimates. RBC Capital Markets’ Srini Pajjuri highlights supply constraints at Intel that might keep pushing server CPU orders AMD’s way, while competition from Arm Holdings adds uncertainty. Several analysts are predicting a “beat-and-raise” — results and guidance topping expectations. MarketWatch

Sentiment took a hit after Reuters reported late Monday that OpenAI is exploring alternatives to certain Nvidia chips, eyeing deals with AMD and startups like Cerebras and Groq, according to sources familiar with the matter. The focus is on the “inference” stage—when a trained model produces answers—even though OpenAI still depends heavily on Nvidia hardware. OpenAI CEO Sam Altman posted on X that Nvidia makes “the best AI chips in the world,” while Nvidia said customers choose its gear for “best performance” at scale. Reuters

AMD jumped 4% on Monday, riding a wave of enthusiasm for AI spending that pushed chipmakers higher. The S&P 500 ended the day up, narrowly missing a record close. Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder, noted that “the fundamentals are good and earnings are strong” as investors dive deeper into earnings season. Reuters

HSBC’s Frank Lee bumped up his price target for AMD to $335 while maintaining a buy rating. He pointed to a boost in server demand driven by “agentic AI” — AI software agents capable of handling multi-step tasks. Barron’s

Another earnings preview showed consensus estimates pointing to about 27% year-over-year revenue growth, following a quarter where AMD reported $9.25 billion in sales and exceeded revenue expectations.

In early trading, Nvidia dropped roughly 2.9%, while Intel climbed around 5%, highlighting the rapid shifts in sentiment within the semiconductor sector ahead of earnings.

Expectations are climbing, though. A wary stance on data-center spending, a slower AI accelerator rollout, or margin squeeze from pricing could weigh on the stock despite its pre-earnings gains. The OpenAI factor might turn out to be more indirect—major clients can trial new chips without triggering significant volume shifts.

AMD is set to release its fiscal fourth-quarter and full-year 2025 results and hold an earnings webcast at 5:00 p.m. EST on Feb. 3, per its investor relations calendar. The company’s guidance and remarks on inference demand and key customer orders could move shares when markets open Feb. 4.

Stock Market Today

  • Yacktman Asset Management Cuts Alphabet Inc. Stake Amid Mixed Institutional Moves
    May 19, 2026, 2:13 PM EDT. Yacktman Asset Management LP reduced its stake in Alphabet Inc. (NASDAQ:GOOG) by 3.1% in Q4, selling 36,606 shares and holding 1,129,807 shares valued at $354.5 million, representing 5% of its portfolio. Other institutional investors showed varied activity with Brighton Jones LLC and Worldquant Millennium Advisors LLC increasing their holdings significantly. Alphabet's stock saw multiple analyst ratings, including 'outperform' and 'buy' with target prices ranging from $345 to $450, reflecting positive sentiment from firms like Scotiabank, TD Cowen, and Deutsche Bank. Institutional investors own 27.26% of Alphabet's shares. The stock remains a top focus amid ongoing trading by hedge funds and asset managers.

Latest articles

Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

Recursion Stock Slumps to 52-Week Low as Traders Eye FDA News

19 May 2026
Recursion Pharmaceuticals shares fell 2.2% to $2.825 Tuesday, hitting a 52-week low of $2.77, after reporting first-quarter revenue of $6.47 million, down from $14.75 million a year earlier. Net loss narrowed to $117.5 million. Early clinical data for REC-1245 showed no dose-limiting toxicities in 16 solid-tumor patients. The company ended March with $665.2 million in cash.
Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

Wall Street’s Top Picks for U.S. Stocks as Yields Stay High

19 May 2026
U.S. stocks fell Tuesday as the 10-year Treasury yield reached its highest point since January 2025, pressuring growth shares. Nvidia drew the most attention ahead of its earnings, with options markets pricing in a possible $355 billion swing in value. Dell highlighted new AI infrastructure partnerships, while ServiceNow received a fresh Buy rating from Bank of America.
Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

19 May 2026
Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Aviva share price today: stock ticks up after Lloyd’s launch, with March results next
Previous Story

Aviva share price today: stock ticks up after Lloyd’s launch, with March results next

Dow Jones futures barely budge after 515-point pop as shutdown vote, data delays cloud Wall Street
Next Story

Dow Jones futures barely budge after 515-point pop as shutdown vote, data delays cloud Wall Street

Go toTop